A Pulitzer Prize-winning journalism website that fact-checks politicians’ claims has waded into the controversy over whether President Biden raised insulin prices by freezing a 340B-related Trump administration regulation.
On Feb. 11, the Poynter Institute’s PolitiFact site rated U.S. Senate candidate Mark Walker’s (R-N.C.) Jan. 22 tweet that Biden “is raising the prices of insulin and Epi-Pens on those with high costs and the uninsured” as Mostly False. Walker chose not to run for re-election to the U.S. House in 2020, choosing instead to seek the Senate seat held by Richard Burr (R-N.C.), who is not seeking reelection in 2022.
A Pulitzer Prize-winning journalism website that fact-checks politicians’ claims has waded into the controversy over whether President Biden raised insulin prices by freezing a 340B-related Trump administration regulation.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
